Citigroup Confirms Buy Recommendation for Rentokil Initial plc - Depositary Receipt (RTO)

Zacks Rank Upgrade: Rentokil Initial PLC has been upgraded to a Zacks Rank #2 (Buy), indicating a positive outlook on its earnings estimates, which could lead to increased stock prices.

Earnings Estimate Revisions: The Zacks rating system emphasizes the importance of earnings estimate revisions, showing a strong correlation with near-term stock movements, making Rentokil a solid candidate for potential market-beating returns.

Analyst Consensus: Over the past three months, the Zacks Consensus Estimate for Rentokil has increased by 0.3%, reflecting analysts' growing confidence in the company's earnings potential.

Historical Performance: The Zacks Rank system has a proven track record, with Zacks Rank #1 stocks averaging a +25% annual return since 1988, highlighting the effectiveness of tracking earnings estimates for investment decisions.

Citigroup's Recommendation: On October 24, 2025, Citigroup reiterated a Buy recommendation for Rentokil Initial plc - Depositary Receipt (NYSE:RTO), despite an average one-year price target suggesting a 4.39% downside from its current price of $29.31/share.

Projected Revenue and EPS: Rentokil Initial plc is projected to have an annual revenue of $6,094 million, reflecting a 10.12% increase, with a non-GAAP EPS forecast of 0.28.

Fund Sentiment: There are 471 funds reporting positions in Rentokil Initial, with a 5.99% decrease in the number of owners over the last quarter, while total shares owned by institutions increased by 6.46% to 393,907K shares.

Shareholder Activity: Notable changes in shareholder positions include significant increases by AEPGX and OAKIX, while BLACKROCK EQUITY DIVIDEND FUND reported a decrease in shares owned, indicating varied investment strategies among major funds.

UBS Coverage and Price Forecast: UBS has reiterated a Neutral recommendation for Rentokil Initial plc - Depositary Receipt (NYSE:RTO) with an average one-year price target of $28.02/share, indicating a potential upside of 4.76% from its current price of $26.75/share.

Fund Sentiment and Institutional Holdings: There are 470 funds reporting positions in RTO, with a slight decrease in the number of owners but an increase in total shares owned by institutions by 6.46% over the last three months, reflecting a bullish outlook indicated by a put/call ratio of 0.56.

Rodent Infestation Trends: The 2024 Top 50 Most Rodent-Infested U.S. Cities Report from Terminix highlights a surge in rodent infestations, driven by urban growth, warmer weather, and the movement of rodents with people, posing risks to homeowners.

Prevention Tips for Homeowners: Terminix advises homeowners to seal entry points, protect food sources, and maintain their yards to prevent rodent infestations, emphasizing that proactive measures can help avoid costly damage and health hazards.

Stock Performance Overview: RTO's stock has a 52-week low of $19.60 and a high of $34.07, with the last trade recorded at $24.38.

Author's Perspective Disclaimer: The opinions expressed in the article are solely those of the author and do not necessarily represent Nasdaq, Inc.

Stock Performance Overview: RTO's stock has a 52-week low of $19.60 and a high of $34.07, with the last trade recorded at $24.49.

Disclaimer on Opinions: The views expressed in the article are those of the author and do not necessarily represent Nasdaq, Inc.